Recruiting

STEPP-Care

Sponsor:

Brigham and Women's Hospital

Code:

NCT07577674

Conditions

Hematopoietic Stem Cell Transplantation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

STEPP-Care

Study Details

Brief summary:

The main purpose of this study is to determine if a tailored peer support intervention (STEPP-Care) is feasible among caregivers of patients undergoing hematopoietic stem cell transplantation (HSCT).

Conditions

Hematopoietic Stem Cell Transplantation

Study ID

NCT07577674

Start date

Oct 19, 2026

Status verified date

Nov, 2026

Completion date

Sep 30, 2031

Anticipated

Primary completion date

Sep 30, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Adult caregivers (≥18 years of age) of patients with hematologic malignancies who are undergoing autologous or allogeneic HSCT at Dana-Farber Cancer Institute.
  • Is a relative or friend who is identified by the patient to be their caregiver.
  • Ability to speak, read, and respond in English
  • Has access to a phone.

Exclusion Criteria:

  • Caregivers with acute or unstable psychiatric conditions or other cognitive conditions that the treating oncologist believes would prohibit informed consent or ability to adhere to study procedures.

Study Design

Enrollment

90 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Supportive Care

Interventions and Outcome Measures

Arms

experimental: STEPP-Care

STEPP-Care is a phone delivered six session structured peer support intervention.

no intervention: Usual Care

Routine supportive care provided by social workers embedded in the HCT clinical teams will be used as the usual care control condition.

Interventions

STEPP-Care

STEPP-Care is a phone-delivered six-session structured peer support intervention for caregivers of patients undergoing hematopoietic stem cell transplantation.

Primary outcome measure

  • Intervention Feasibility [ Time Frame: up to 10 weeks ]
  • Intervention Acceptability [ Time Frame: up to 10 weeks ]

Central Contacts and Locations

Central contacts

Hermioni L. Amonoo, MD, MPP, MPH

617-525-7472hermioni_amonoo@dfci.harvard.edu

Josephine Monahan, BA

jamonahan@bwh.harvard.edu

Locations

Dana Farber Cancer Institute

Recruiting

Boston, Massachusetts, United States, 02215

Contacts

Principal Investigator:

Hermioni Amonoo, MD, MPP, MPH

More Information

Sponsor

Brigham and Women's Hospital

Last update posted

Nov 18, 2026

Last verified

Nov, 2026

Keywords

  • Caregivers
  • Stem Cell Transplantation

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-19. This information was provided to ClinicalTrials.gov by Brigham and Women's Hospital on 2026-11-18. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.